Amgen Recasts Growth Story With Product Momentum And Long Dated Funding - simplywall.st
Amgen Recasts Growth Story With Product Momentum And Long Dated Funding simplywall.st
Amgen Company News
Amgen Inc. (AMGN): A Bull Case Theory - Finviz
Amgen Inc. (AMGN): A Bull Case Theory Finviz
Primecap Management Co. CA Decreases Stock Position in Amgen Inc. $AMGN - MarketBeat
Primecap Management Co. CA Decreases Stock Position in Amgen Inc. $AMGN MarketBeat
2025 at Amgen: Investing, Expanding, and Serving More Patients - Amgen
2025 at Amgen: Investing, Expanding, and Serving More Patients Amgen
Amgen stock hits all-time high at 385.63 USD - Investing.com
Amgen stock hits all-time high at 385.63 USD Investing.com
Here’s What the Street is Saying About Amgen Inc. (AMGN) - Yahoo Finance
Here’s What the Street is Saying About Amgen Inc. (AMGN) Yahoo Finance
Is Amgen Stock Outperforming the Dow? - Barchart.com
Is Amgen Stock Outperforming the Dow? Barchart.com
US Bancorp DE Has $194 Million Holdings in Amgen Inc. $AMGN - MarketBeat
US Bancorp DE Has $194 Million Holdings in Amgen Inc. $AMGN MarketBeat
Amgen Once Again Recognized as Top Pharma Company by U.S. Patients - Amgen
Amgen Once Again Recognized as Top Pharma Company by U.S. Patients Amgen
Mitsubishi UFJ Asset Management Co. Ltd. Boosts Stock Position in Amgen Inc. $AMGN - MarketBeat
Mitsubishi UFJ Asset Management Co. Ltd. Boosts Stock Position in Amgen Inc. $AMGN MarketBeat
Amgen Breaks Ground on $600 Million Center for Science and Innovation in Thousand Oaks, Calif. - Amgen
Amgen Breaks Ground on $600 Million Center for Science and Innovation in Thousand Oaks, Calif. Amgen
Harvest Portfolios Group Inc. Boosts Holdings in Amgen Inc. $AMGN - MarketBeat
Harvest Portfolios Group Inc. Boosts Holdings in Amgen Inc. $AMGN MarketBeat
Argent Trust Co Lowers Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Argent Trust Co Lowers Stock Holdings in Amgen Inc. $AMGN MarketBeat
RWA Wealth Partners LLC Increases Holdings in Amgen Inc. $AMGN - MarketBeat
RWA Wealth Partners LLC Increases Holdings in Amgen Inc. $AMGN MarketBeat
TD Asset Management Inc Has $108.85 Million Stock Holdings in Amgen Inc. $AMGN - MarketBeat
TD Asset Management Inc Has $108.85 Million Stock Holdings in Amgen Inc. $AMGN MarketBeat
MAI Capital Management Has $21.81 Million Holdings in Amgen Inc. $AMGN - MarketBeat
MAI Capital Management Has $21.81 Million Holdings in Amgen Inc. $AMGN MarketBeat
Intech Investment Management LLC Has $13.65 Million Position in Amgen Inc. $AMGN - MarketBeat
Intech Investment Management LLC Has $13.65 Million Position in Amgen Inc. $AMGN MarketBeat
Amgen Inc. $AMGN Stock Holdings Boosted by Allianz SE - MarketBeat
Amgen Inc. $AMGN Stock Holdings Boosted by Allianz SE MarketBeat
Dakota Wealth Management Has $9.15 Million Holdings in Amgen Inc. $AMGN - MarketBeat
Dakota Wealth Management Has $9.15 Million Holdings in Amgen Inc. $AMGN MarketBeat
Handelsbanken Fonder AB Sells 47,932 Shares of Amgen Inc. $AMGN - MarketBeat
Handelsbanken Fonder AB Sells 47,932 Shares of Amgen Inc. $AMGN MarketBeat
Erste Asset Management GmbH Decreases Position in Amgen Inc. $AMGN - MarketBeat
Erste Asset Management GmbH Decreases Position in Amgen Inc. $AMGN MarketBeat
Empirical Asset Management LLC Has $306,000 Position in Amgen Inc. $AMGN - MarketBeat
Empirical Asset Management LLC Has $306,000 Position in Amgen Inc. $AMGN MarketBeat
Amgen Inc. $AMGN Shares Purchased by Sumitomo Mitsui Financial Group Inc. - MarketBeat
Amgen Inc. $AMGN Shares Purchased by Sumitomo Mitsui Financial Group Inc. MarketBeat
Amgen’s New UPLIZNA Nod and $4 Billion Bond Sale Might Change The Case For Investing In Amgen (AMGN) - simplywall.st
Amgen’s New UPLIZNA Nod and $4 Billion Bond Sale Might Change The Case For Investing In Amgen (AMGN) simplywall.st
Amgen Inc. $AMGN Shares Sold by M. Kulyk & Associates LLC - MarketBeat
Amgen Inc. $AMGN Shares Sold by M. Kulyk & Associates LLC MarketBeat
Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It Yahoo Finance
EverSource Wealth Advisors LLC Has $5.40 Million Holdings in Amgen Inc. $AMGN - MarketBeat
EverSource Wealth Advisors LLC Has $5.40 Million Holdings in Amgen Inc. $AMGN MarketBeat
Amgen (NASDAQ:AMGN) Sets New 52-Week High - Here's What Happened - MarketBeat
Amgen (NASDAQ:AMGN) Sets New 52-Week High - Here's What Happened MarketBeat
Barclays Begins Amgen (AMGN) Coverage, Notes Balanced Outlook Despite Trial Debate - Yahoo Finance
Barclays Begins Amgen (AMGN) Coverage, Notes Balanced Outlook Despite Trial Debate Yahoo Finance
Here’s What Argus Research and Guggenheim Are Saying About Amgen Inc. (AMGN) - Yahoo Finance
Here’s What Argus Research and Guggenheim Are Saying About Amgen Inc. (AMGN) Yahoo Finance
Is Amgen (AMGN) Still Attractively Priced After Strong Multi Year Share Price Gains - simplywall.st
Is Amgen (AMGN) Still Attractively Priced After Strong Multi Year Share Price Gains simplywall.st
Amgen Q4 results beat Street estimates, company says patients need weight-loss options - Reuters
Amgen Q4 results beat Street estimates, company says patients need weight-loss options Reuters
EUROPEAN COMMISSION APPROVES AMGEN'S UPLIZNA® FOR GENERALIZED MYASTHENIA GRAVIS - PR Newswire
EUROPEAN COMMISSION APPROVES AMGEN'S UPLIZNA® FOR GENERALIZED MYASTHENIA GRAVIS PR Newswire
Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know - Yahoo Finance
Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know Yahoo Finance
Amgen Advances Maridebart Cafraglutide Toward Mid-Stage Obesity and Liver Fat Trial - TipRanks
Amgen Advances Maridebart Cafraglutide Toward Mid-Stage Obesity and Liver Fat Trial TipRanks
Generative AI Tools Support Amgen’s Mission to Serve Patients - Amgen
Generative AI Tools Support Amgen’s Mission to Serve Patients Amgen
AMGEN REPORTS FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS - PR Newswire
AMGEN REPORTS FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS PR Newswire
Amgen buys protein-degrading startup Dark Blue for up to $840M - BioPharma Dive
Amgen buys protein-degrading startup Dark Blue for up to $840M BioPharma Dive
45 Years of Amgen - Amgen
45 Years of Amgen Amgen
AMGEN REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS - PR Newswire
AMGEN REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS PR Newswire